Complications of Aesthetic and Reconstructive Breast Implant Capsulectomy: An Analysis of 7486 Patients Using Nationwide Outcomes Data

Hong Hao Xu,Jad Abi-Rafeh,Peter Davison,Sebastian Winocour,Evan Matros,Joshua Vorstenbosch

DOI: https://doi.org/10.1093/asj/sjae068

2024-03-22

Aesthetic Surgery Journal

Abstract:Abstract Background Despite increasing demand for breast capsular surgery to treat various benign and malignant implant-related pathologies, high-quality evidence elucidating complication profiles of capsulectomy and capsulotomy is lacking. Objectives We provide the largest-scale analysis of associated outcomes and complications using the Tracking Operations and Outcomes for Plastic Surgeons (TOPS) database, and investigate clinical scenarios that may subject patients to increased risks for complications, most notably, extent of capsular surgery (complete vs partial), and index indication of implantation (aesthetic vs reconstructive). Methods An analysis of the TOPS database from 2008-2019 was performed. CPT codes were used to identify complete capsulectomy and partial capsulectomy/capsulotomy cases. Breast implant exchange procedures constituted procedural controls. Results In total, 7,486 patients (10,703 breasts) undergoing capsulectomy or capsulotomy were assessed. Relative to controls, capsulectomy (4.40% vs 5.79%; p = 0.0154), but not capsulotomy (4.40% vs 4.50%; p = 0.8876), demonstrated higher overall complication rates. Both capsulectomies (0.83% vs 0.23%; p < 0.0001) and capsulotomies (0.56% vs 0.23%; p = 0.0307) also had greater rates of seroma relative to controls. Subgroup analyses demonstrated that reconstructive patients, relative to aesthetic patients, experienced greater overall complications (6.76% vs 4.34%; p < 0.0001), and increased risks for seroma (1.06% vs 0.47%; p = 0.0016), dehiscence (0.46% vs 0.14%; p = 0.0059), surgical site infections (1.03% vs 0.23%; p < 0.0001), and implant loss (0.52% vs 0.23%; p = 0.0401). A detailed synthesis of 30-day outcomes, including all patient- and breast-specific complications, for both capsulectomy and capsulotomy, stratified according to all potential confounders, is presented herein. Conclusions Surgeries on the breast capsule are overall safe, though complete capsulectomies and reconstructive patients were associated with significantly increased operative risks. Present findings will enhance patient selection, counselling, and informed consent.

surgery

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve

This paper aims to address the complications associated with capsulectomy and capsulotomy in cosmetic and reconstructive surgeries by analyzing nationwide data. Specifically, the research objectives include:

1. **Providing a large-scale complication analysis**: Utilizing the American Society of Plastic Surgeons (ASPS) "Tracking Operations and Outcomes for Plastic Surgeons" (TOPS) database to conduct a large-scale analysis of complications in 7486 patients.
2. **Exploring risk differences between different surgical types**: Investigating the differences in complication rates between total capsulectomy and partial capsulectomy/capsulotomy.
3. **Evaluating the impact of the initial surgical purpose**: Comparing the complication risks in patients undergoing capsulectomy or capsulotomy for cosmetic versus reconstructive purposes.
4. **Providing clinical guidance**: Offering scientific evidence for patient selection, preoperative counseling, and informed consent through detailed data analysis.

### Background and Motivation

In recent years, the demand for breast capsulectomy has been rising due to the increase in benign and malignant pathologies related to breast implants. However, there is a lack of high-quality evidence to fully understand the complications associated with capsulectomy and capsulotomy. Existing studies have limitations such as small sample sizes, narrow time spans, single-center perspectives, and a lack of detailed consideration of surgical types. Therefore, further detailed and evidence-based research is needed to better elucidate the risks of these surgeries.

### Methods

- **Data Source**: Using the TOPS database, covering data from 2008 to 2019.
- **Study Subjects**: Including patients undergoing total capsulectomy, partial capsulectomy/capsulotomy, and a control group of patients undergoing only implant replacement.
- **Data Analysis**: Data processing using Python and Microsoft Excel, and statistical analysis using GraphPad Prism.

### Main Findings

- **Overall Complication Rate**: The complication rate for total capsulectomy was significantly higher than the control group (5.79% vs 4.40%, p=0.0154), while the complication rate for capsulotomy showed no significant difference from the control group (4.50% vs 4.40%, p=0.8876).
- **Specific Complications**: The incidence of seroma was higher in both total capsulectomy and capsulotomy compared to the control group (0.83% vs 0.23%, p<0.0001; 0.56% vs 0.23%, p=0.0307, respectively).
- **Subgroup Analysis**: Reconstructive surgery patients had a higher overall complication rate compared to cosmetic surgery patients (6.76% vs 4.34%, p<0.0001), with higher risks of seroma, wound dehiscence, surgical site infection, and implant loss.

### Conclusion

Although breast capsulectomy is generally safe, the risks are significantly increased for total capsulectomy and reconstructive surgery patients. These findings will aid in patient selection, preoperative counseling, and informed consent, thereby improving the quality of clinical decision-making.